The Chronic Lymphocytic Leukemia Channel on VJHemOnc is an independent medical education platform, supported with funding from AstraZeneca (Diamond), AbbVie (Platinum), BeOne Medicines (Silver) and Lilly (Silver). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
iwCLL 2023 | The importance of vaccination and vaccine responsiveness in patients with CLL
Chris Pleyer, MD, The National Institute of Health, Bethesda, MD, discusses the importance of vaccination in patients with chronic lymphocytic leukemia (CLL), an area which was poorly understood until the COVID-19 pandemic, in which widespread vaccination against the disease took place. Dr Pleyer also considers factors which affect vaccine responsiveness in individuals with CLL, such as type of treatment, and briefly describes how immune responses to vaccination can be improved. This interview was recorded at the biennial International Workshop on Chronic Lymphocytic Leukemia (iwCLL) 2023 meeting, held in Boston, MA.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
